Asymmetric Unit (11, 11)
No. | Name | Evidence | Residues | Description |
01 | AC1 | SOFTWARE | G A:8 , A A:9 , C A:10 , G A:11 | binding site for residue GAI A 101 |
02 | AC2 | SOFTWARE | G B:8 , A B:9 , C B:10 , G B:11 | binding site for residue GAI B 101 |
03 | AC3 | SOFTWARE | G B:8 | binding site for residue NA B 102 |
04 | AC4 | SOFTWARE | G C:8 , A C:9 , C C:10 , G C:11 | binding site for residue GAI C 101 |
05 | AC5 | SOFTWARE | G D:8 , A D:9 , C D:10 , G D:11 | binding site for residue GAI D 101 |
06 | AC6 | SOFTWARE | G A:7 , G A:8 , G B:4 , C B:5 , A B:6 , U B:15 , A B:18 , HOH B:202 , HOH B:203 | binding site for Di-nucleotide G B 16 and CBV B 17 |
07 | AC7 | SOFTWARE | G A:8 , U B:3 , G B:4 , G B:16 , A B:19 , HOH B:202 , HOH B:203 | binding site for Di-nucleotide CBV B 17 and A B 18 |
08 | AC8 | SOFTWARE | G C:4 , C C:5 , A C:6 , U C:15 , A C:18 , G D:7 , G D:8 | binding site for Di-nucleotide G C 16 and CBV C 17 |
09 | AC9 | SOFTWARE | U C:3 , G C:4 , C C:5 , G C:16 , A C:19 , G D:8 | binding site for Di-nucleotide CBV C 17 and A C 18 |
10 | AD1 | SOFTWARE | G C:8 , G D:4 , C D:5 , A D:6 , U D:15 , A D:18 | binding site for Di-nucleotide G D 16 and CBV D 17 |
11 | AD2 | SOFTWARE | U B:2 , G C:8 , U D:3 , G D:4 , C D:5 , G D:16 , A D:19 | binding site for Di-nucleotide CBV D 17 and A D 18 |
|